Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,037
Closed -$212K 212
2021
Q1
$212K Buy
5,037
+132
+3% +$5.99K 0.09% 188
2020
Q4
$225K Hold
4,905
0.1% 180
2020
Q3
$230K Buy
4,905
+411
+9% +$20.6K 0.11% 169
2020
Q2
$229K Buy
+4,494
New +$231K 0.14% 150
2019
Q3
Sell
-9,834
Closed -$492K 361
2019
Q2
$492K Buy
9,834
+4,360
+80% +$219K 0.17% 121
2019
Q1
$286K Buy
5,474
+1,200
+28% +$60K 0.16% 112
2018
Q4
$204K Buy
+4,274
New +$210K 0.13% 131

Other funds holding GSK

Essex Savings Bank's GSK Position: Q2 2021 in Review

Essex Savings Bank sold out of GSK (GSK) in Q2 2021, closing a stake of 5,037 shares — an estimated $212K sold.

Essex Savings Bank first reported a position in GSK in Q4 2018 and held it in 7 quarters. The position peaked at $492K in Q2 2019. 799 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

  • Essex Savings Bank reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
  • Essex Savings Bank sold 5,037 GSK shares in Q2 2021, an estimated $212K.
  • Essex Savings Bank first reported a position in GSK in Q4 2018 and held it in 7 quarters.
  • Essex Savings Bank's GSK position peaked at $492K in Q2 2019.
  • 799 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Essex Savings Bank's 13F filing for Q2 2021, filed 29 Jul 2021.